Phibro Animal Health - Class A (PAHC) closed at $32.96 on November 6, 2026, down 6.9% from the previous close, on volume of 273,480 shares (30-day average 214,002).
Data as of November 6, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 16, 2026 | Diagonal Call Spread | 16-Oct : 20-Nov-2635 : 40 C | 400 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Phibro Animal Health Reports Strong First-Quarter Financial Results
TipRanks (Wed, 4-Nov 5:56 PM ET)
Phibro Animal Non-GAAP EPS of $0.79 beats by $0.01, revenue of $386.6M beats by $3.6M
Seeking Alpha News (Wed, 4-Nov 4:45 PM ET)
Phibro Animal Health Corporation Reports First Quarter Results, Maintains Financial Guidance
Business Wire (Wed, 4-Nov 4:22 PM ET)
Phibro Animal Q1 2027 Earnings Preview
Seeking Alpha News (Wed, 4-Nov 10:07 AM ET)
Phibro Animal Health Corporation Declares Quarterly Dividend
Business Wire (Tue, 3-Nov 4:10 PM ET)
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
Business Wire (Wed, 28-Oct 4:30 PM ET)
Business Wire (Wed, 9-Sep 4:30 PM ET)
Business Wire (Wed, 26-Aug 4:20 PM ET)
Business Wire (Wed, 19-Aug 4:30 PM ET)
Market Chameleon (Fri, 19-Dec 3:42 AM ET)
Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. It develop, manufacture and market products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. It has three segments Animal Health, Mineral Nutrition, and Performance Products. Majority of revenue comes from Animal Health segment. Animal health products are anti-bacterials, anticoccidials, nutritional specialty products, and vaccines, and vaccine adjuvants that help improve the animal's health.
Phibro Animal Health - Class A trades on the NASDAQ stock market under the symbol PAHC.
As of November 9, 2026, PAHC stock price climbed to $34.78 with 169,695 million shares trading.
PAHC has a beta of -0.27, meaning it tends to be less sensitive to market movements. PAHC has a correlation of 0.00 to the broad based SPY ETF.
PAHC has a market cap of $1.41 billion. This is considered a Small Cap stock.
Last quarter Phibro Animal Health - Class A reported $387 million in Revenue and $.79 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.01.
In the last 3 years, PAHC traded as high as $60.08 and as low as $9.40.
The top ETF exchange traded funds that PAHC belongs to (by Net Assets): IJR, VTI, IWM, VXF, IWO.
PAHC has underperformed the market in the last year with a price return of -18.1% while the SPY ETF gained +13.7%. PAHC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -1.7% and -10.4%, respectively, while the SPY returned -1.6% and -0.7%, respectively.
PAHC support price is $31.99 and resistance is $33.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PAHC shares will trade within this expected range on the day.
